iBio Provides Update on IBIO-201 COVID-19 Vaccine Program
NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biotechnology corporation and […]
Brown & Brown, Inc. Enters Into Agreement to Acquire Hauser
DAYTONA BEACH, Fla., Aug. 10, 2020 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. […]
VSBLTY AND ONYX-COGNIVAS TO DEPLOY DIGITAL MEDIA SOLUTIONS IN SOUTH AFRICAN CONVENIENCE STORE CHAIN
Philadelphia, PA, Aug. 10, 2020 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF) (“VSBLTY”), a […]
Gilat Awarded Over $10 Million for a Five-Year Service Project for 4G Backhaul Services in Latin America
PETAH TIKVA, Israel, Aug. 10, 2020 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in […]
Axsome Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
Two NDA submissions, for AXS-05 in MDD and for AXS-07 in migraine, on track for 4Q 2020 Enrollment completed for […]
Helius Medical Technologies to Release Second Quarter of Fiscal Year 2020 Financial Results on August 12, 2020
NEWTOWN, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]
Neos Therapeutics Reports Second Quarter 2020 Financial Results
DALLAS and FORT WORTH, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company […]
Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations
EWING, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today […]
Morphic Announces Corporate Highlights and Second Quarter 2020 Financial Results
Company’s first IND accepted by FDA for MORF-057 in IBDPhase 1 study expected to begin in third-quarter 2020Positive data presented […]
Kamada Announces Enrollment of First Patient in its Phase 1/2 Clinical Trial of its Plasma-Derived Immunoglobulin (IgG) Product as a Potential Treatment for Coronavirus Disease (COVID-19) in Israel
Study Participants are Hospitalized, Non-ventilated COVID-19 Patients with Pneumonia Encouraging Neutralization Activity Observed with Virus Neutralization AssayPre-IND Meeting with U.S. FDA [...]
